Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.
Institute of Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, 4132, Muttenz, Switzerland.
Pharm Res. 2021 Nov;38(11):1889-1896. doi: 10.1007/s11095-021-03123-8. Epub 2021 Oct 25.
To understand drug solubilization as a function of age and identify drugs at risk of altered drug solubility in pediatric patients. To assess the discrimination ability of the Abraham solvation parameters and age-related changes in simulated media composition to predict in vitro drug solubility differences between pediatric and adult gastrointestinal conditions by multivariate data analysis.
Differences between drug solubility in pediatric and adult biorelevant media were expressed as a % pediatric-to-adult ratio [Sp/Sa (%)]. Solubility ratios of fourteen poorly water-soluble drugs (2 amphoteric; 4 weak acids; 4 weak bases; 4 neutral compounds) were used in the analysis. Partial Least Squares Regression was based on Abraham solvation parameters and age-related changes in simulated gastrointestinal fluids, as well as their interactions, to predict the pediatric-to-adult solubility ratio.
The use of Abraham solvation parameters was useful as a theory-informed set of molecular predictors of drug solubility changes between pediatric and adult simulated gastrointestinal fluids. Our findings suggest that the molecular solvation environment in the fasted gastric state was similar in the pediatric age-groups studied, which led to fewer differences in the pediatric-to-adult solubility ratio. In the intestinal fasted and fed state, there was a high relative contribution of the physiologically relevant surfactants to the alteration of drug solubility in the pediatric simulated conditions compared to the adult ones, which confirms the importance of an age-appropriate composition in biorelevant media.
Statistical models based on Abraham solvation parameters were applied mostly to better understand drug solubility differences in adult and pediatric biorelevant media.
了解药物溶解度随年龄的变化,并确定儿科患者中可能改变药物溶解度的药物。通过多变量数据分析,评估 Abraham 溶剂化参数和模拟介质组成中与年龄相关的变化对预测儿科和成人胃肠道条件下药物体外溶解度差异的区分能力。
用小儿与成人生物相关介质中药物溶解度的差异表示为小儿与成人的比值[Sp/Sa(%)]。在分析中使用了 14 种水溶性差的药物(2 种两性;4 种弱酸;4 种弱碱;4 种中性化合物)的溶解度比值。偏最小二乘回归基于 Abraham 溶剂化参数和模拟胃肠道液中的年龄相关变化以及它们的相互作用,预测小儿与成人溶解度比值。
使用 Abraham 溶剂化参数作为小儿和成人模拟胃肠道液中药物溶解度变化的理论指导的分子预测因子是有用的。我们的研究结果表明,在研究的小儿年龄组中,空腹胃状态下的分子溶剂化环境相似,导致小儿与成人溶解度比值的差异较小。在肠道空腹和进食状态下,与成人相比,生理相关表面活性剂对小儿模拟条件下药物溶解度的改变有较高的相对贡献,这证实了生物相关介质中适当年龄组成的重要性。
基于 Abraham 溶剂化参数的统计模型主要用于更好地理解成人和小儿生物相关介质中药物溶解度的差异。